Investment Analysts’ updated eps estimates for Sunday, September 17th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $49.00 price target on the stock.

Adamas Pharmaceuticals (NASDAQ:ADMS) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $38.00 target price on the stock.

Aerie Pharmaceuticals (NASDAQ:AERI) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $65.00 price target on the stock.

AGCO Corporation (NYSE:AGCO) had its hold rating reaffirmed by analysts at Piper Jaffray Companies. They currently have a $66.00 target price on the stock.

Amphastar Pharmaceuticals (NASDAQ:AMPH) had its buy rating reiterated by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $19.00 price target on the stock.

Anadarko Petroleum Corporation (NYSE:APC) had its buy rating reissued by analysts at Cowen and Company. Cowen and Company currently has a $60.00 target price on the stock.

AXT (NASDAQ:AXTI) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $10.00 target price on the stock.

Cigna Corporation (NYSE:CI) had its buy rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $191.00 target price on the stock.

Cinemark Holdings (NYSE:CNK) had its buy rating reaffirmed by analysts at Piper Jaffray Companies.

Corium International (NASDAQ:CORI) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $13.00 target price on the stock.

Cytokinetics, (NASDAQ:CYTK) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $22.00 target price on the stock.

Dermira (NASDAQ:DERM) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $46.00 target price on the stock.

Digimarc Corporation (NASDAQ:DMRC) had its buy rating reiterated by analysts at Cowen and Company. They currently have a $50.00 price target on the stock.

ChannelAdvisor Corporation (NYSE:ECOM) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $18.00 target price on the stock.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) had its hold rating reaffirmed by analysts at Piper Jaffray Companies. They currently have a $9.00 target price on the stock.

First Connecticut Bancorp (NASDAQ:FBNK) had its hold rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $26.00 target price on the stock.

The Finish Line (NASDAQ:FINL) had its hold rating reaffirmed by analysts at Cowen and Company. Cowen and Company currently has a $13.00 target price on the stock.

Flexion Therapeutics (NASDAQ:FLXN) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $36.00 price target on the stock.

BMO Capital Markets began coverage on shares of Federal Realty Investment Trust (NYSE:FRT). BMO Capital Markets issued an outperform rating and a $145.00 target price on the stock.

Hi-Crush Partners (NYSE:HCLP) had its buy rating reaffirmed by analysts at Cowen and Company. They currently have a $12.00 price target on the stock.

HealthSouth Corporation (NYSE:HLS) had its hold rating reissued by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $50.00 target price on the stock.

Imax Corporation (NYSE:IMAX) had its buy rating reissued by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $28.00 target price on the stock.

Ionis Pharmaceuticals (NASDAQ:IONS) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $64.00 target price on the stock.

Impax Laboratories (NASDAQ:IPXL) had its hold rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $17.00 target price on the stock.

Laredo Petroleum (NYSE:LPI) had its hold rating reiterated by analysts at Cowen and Company. The firm currently has a $12.00 target price on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $21.00 target price on the stock.

Murphy Oil Corporation (NYSE:MUR) had its hold rating reissued by analysts at Cowen and Company. They currently have a $30.00 price target on the stock.

Myriad Genetics (NASDAQ:MYGN) had its hold rating reissued by analysts at Cowen and Company. Cowen and Company currently has a $25.00 target price on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $58.00 target price on the stock.

NBT Bancorp (NASDAQ:NBTB) had its hold rating reiterated by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $35.00 price target on the stock.

Netflix (NASDAQ:NFLX) had its hold rating reiterated by analysts at Needham & Company LLC.

Nike (NYSE:NKE) had its hold rating reiterated by analysts at Cowen and Company. They currently have a $54.00 target price on the stock.

Pepsico (NYSE:PEP) had its buy rating reissued by analysts at Cowen and Company.

Plug Power (NASDAQ:PLUG) had its buy rating reissued by analysts at Cowen and Company. They currently have a $3.00 price target on the stock.

Patterson-UTI Energy (NASDAQ:PTEN) had its hold rating reaffirmed by analysts at Cowen and Company. The firm currently has a $24.00 price target on the stock.

Pioneer Natural Resources (NYSE:PXD) had its buy rating reiterated by analysts at Cowen and Company. Cowen and Company currently has a $210.00 price target on the stock.

Qorvo (NASDAQ:QRVO) had its hold rating reiterated by analysts at Cowen and Company. The firm currently has a $85.00 price target on the stock.

Qorvo (NASDAQ:QRVO) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $86.00 target price on the stock.

Ricardo plc (LON:RCDO) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a GBX 1,043 ($13.47) price target on the stock.

Ralph Lauren Corporation (NYSE:RL) had its hold rating reaffirmed by analysts at Cowen and Company. Cowen and Company currently has a $89.00 price target on the stock.

Rockwell Automation (NYSE:ROK) had its hold rating reiterated by analysts at Cowen and Company. Cowen and Company currently has a $140.00 target price on the stock.

SunPower Corporation (NASDAQ:SPWR) had its buy rating reissued by analysts at Cowen and Company. Cowen and Company currently has a $12.00 price target on the stock.

Stratasys (NASDAQ:SSYS) had its hold rating reiterated by analysts at Cowen and Company. They currently have a $23.00 price target on the stock.

Sensata Technologies Holding N.V. (NYSE:ST) had its hold rating reaffirmed by analysts at Cowen and Company. They currently have a $45.00 target price on the stock.

Skyworks Solutions (NASDAQ:SWKS) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $110.00 price target on the stock.

Tiffany & Co. (NYSE:TIF) had its buy rating reissued by analysts at Cowen and Company.

Turning Point Brands (NYSE:TPB) had its buy rating reaffirmed by analysts at Cowen and Company. Cowen and Company currently has a $20.00 target price on the stock.

Tetraphase Pharmaceuticals (NASDAQ:TTPH) had its hold rating reiterated by analysts at Needham & Company LLC.

Unit Corporation (NYSE:UNT) had its hold rating reissued by analysts at Cowen and Company. The firm currently has a $25.00 target price on the stock.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $195.00 target price on the stock.

Valeant Pharmaceuticals International (NYSE:VRX) (TSE:VRX) had its sell rating reiterated by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $14.00 target price on the stock.

Whiting Petroleum Corporation (NYSE:WLL) had its buy rating reissued by analysts at Cowen and Company. Cowen and Company currently has a $8.00 target price on the stock.

Receive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.